Literature DB >> 21232819

Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709-1G>A PGRN mutation associated with FTLD-TDP dementia.

Carolina Alquezar1, Noemí Esteras, Fernando Bartolomé, José J Merino, Ainhoa Alzualde, Adolfo López de Munain, Ángeles Martín-Requero.   

Abstract

Frontotemporal lobar degeneration with neuronal inclusions containing TAR DNA binding protein 43 (TDP-43) is associated in most cases with null-mutations in the progranulin gene (PGRN). While the mechanisms by which PGRN haploinsufficiency leads to neurodegeneration remained speculative, increasing evidence support the hypothesis that cell cycle reentry of postmitotic neurons precedes many instances of neuronal death. Based in the mitogenic and neurotrophic activities of PGRN, we hypothesized that PGRN deficit may induce cell cycle disturbances and alterations in neuronal vulnerability. Because cell cycle dysfunction is not restricted to neurons, we studied the influence of PGRN haploinsufficiency, on cell cycle control in peripheral cells from patients suffering from frontotemporal dementia, bearing the PGRN mutation c.709-1G>A. Here we show that progranulin deficit increased cell cycle activity in immortalized lymphocytes. This effect was associated with increased levels of cyclin-dependent kinase 6 (CDK6) and phosphorylation of retinoblastoma protein (pRb), resulting in a G(1)/S regulatory failure. A loss of function of TDP-43 repressing CDK6 expression may result from altered subcellular TDP-43 distribution. The distinct functional features of lymphoblastoid cells from c.709-1 G>A carriers offer an invaluable, noninvasive tool to investigate the etiopathogenesis of frontotemporal lobar degeneration.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21232819     DOI: 10.1016/j.neurobiolaging.2010.11.020

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson's Disease Patients.

Authors:  Noemí Esteras; Carolina Alquézar; Fernando Bartolomé; Ana de la Encarnación; Félix Bermejo-Pareja; José Antonio Molina; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2014-09-03       Impact factor: 5.590

2.  Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.

Authors:  Carolina Alquézar; Ana de la Encarnación; Fermín Moreno; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

3.  Progranulin Deficiency Reduces CDK4/6/pRb Activation and Survival of Human Neuroblastoma SH-SY5Y Cells.

Authors:  Ana de la Encarnación; Carolina Alquézar; Noemí Esteras; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

4.  Increased Wnt Signaling and Reduced Viability in a Neuronal Model of Progranulin-Deficient Frontotemporal Lobar Degeneration.

Authors:  Ana de la Encarnación; Carolina Alquézar; Ángeles Martín-Requero
Journal:  Mol Neurobiol       Date:  2015-12-17       Impact factor: 5.590

Review 5.  Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.

Authors:  Ya-Qing Li; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2015-11-04       Impact factor: 5.590

6.  Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.

Authors:  Carolina Alquezar; Noemí Esteras; Ainhoa Alzualde; Fermín Moreno; Matilde S Ayuso; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Calmodulin levels in blood cells as a potential biomarker of Alzheimer's disease.

Authors:  Noemí Esteras; Carolina Alquézar; Ana de la Encarnación; Alberto Villarejo; Félix Bermejo-Pareja; Angeles Martín-Requero
Journal:  Alzheimers Res Ther       Date:  2013-11-07       Impact factor: 6.982

8.  Targeting TDP-43 phosphorylation by Casein Kinase-1δ inhibitors: a novel strategy for the treatment of frontotemporal dementia.

Authors:  Carolina Alquezar; Irene G Salado; Ana de la Encarnación; Daniel I Pérez; Fermín Moreno; Carmen Gil; Adolfo López de Munain; Ana Martínez; Ángeles Martín-Requero
Journal:  Mol Neurodegener       Date:  2016-04-30       Impact factor: 14.195

9.  Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia.

Authors:  Maria A Telpoukhovskaia; Kai Liu; Faten A Sayed; Jon Iker Etchegaray; Min Xie; Lihong Zhan; Yaqiao Li; Yungui Zhou; David Le; Ben A Bahr; Matthew Bogyo; Sheng Ding; Li Gan
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.